MedPath

Effectiveness of a selected oral serratiopeptidase in the market in reduction of the lower limb girth of patients with lower limb swelling due to cellulitis

Phase 4
Conditions
cellulitis
Registration Number
SLCTR/2020/008
Lead Sponsor
HSL, Colombo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

•Both males and females
•Above 18 years of age
•Diagnosed with lower limb cellulitis

Exclusion Criteria

•Patients who are on anti-coagulants
•Patients with other significant co-morbidities – congestive heart failure, chronic renal impairment
•Patients who have received antibiotics during this episode prior to this admission.
•Patients with preexisting lymphedema
•Patients who are hypersensitive to penicillin and / or cloxacillin
•Patients who present with septic shock

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
imb circumference will be measured on admission using a tape measurement method [On admission, day 3 and 10 days after admission. ]<br>
Secondary Outcome Measures
NameTimeMethod
one []<br>
© Copyright 2025. All Rights Reserved by MedPath